What is it about?
COPD is characterized by an ongoing inflammatory process of the airways that leads to obstruction or limitation of airflow. It is mainly associated with exposure to cigarette smoke. In addition, it is considered, at present, a serious public health problem, ranking fourth in mortality worldwide. Many cells participate in the pathophysiology of COPD, the most important are neutrophils, macrophages and CD4+ and CD8+ T cells. Neutrophil migration to the inflammation area could be mediated largely by cytokines related to CD4+ Th17 lymphocytes, because it has been shown that IL-17A, IL-17F and IL-22 act as inducers for CXCL8, CXCL1, CXCL5, G-CSF, and GM-CSF secretion by epithelial cells of the airways. The aims of these molecules are differentiation, proliferation and recruitment of neutrophils. Furthermore, it is believed that CD4+ lymphocytes Th17 may be involved in protection against pathogens for which Th1 and Th2 are not prepared to fight. In COPD exacerbations, there is an increased cellularity in the lung region and respiratory tract. Therefore, the increase in the number of neutrophils and macrophages in the airways and the increase in proinflammatory cytokines are directly related to the severity of exacerbations and that is the importance of the functions of Th17 profile in this entity.
Photo by Tim Mossholder on Unsplash
Why is it important?
The pathophysiology in COPD and COPD exacerbations are not completley elucidated. This paper try to explain possible mechanisms involved in this common illness possibly mediated by Th17 profile among smokers.
Read the Original
This page is a summary of: Th17 profile in COPD exacerbations, International Journal of Chronic Obstructive Pulmonary Disease, June 2017, Dove Medical Press, DOI: 10.2147/copd.s136592.
You can read the full text:
The following have contributed to this page